º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Commercial Property

Charnwood Molecular moves into R&D block at Charnwood Campus in Loughborough after £54m refit

Charnwood Molecular helps pharmaceutical and biotech companies around the world with drug development

Charnwood Molecular block at Charnwood Campus

A research block in a life-science industrial park has undergone a £54 million refit for its new tenant.

The owners of the Charnwood Campus life-science hub in Loughborough have recommissioned the synthetic and chemistry research facility to the highest standard to cater to the needs of pre-clinical discovery contract research organisation (CRO) Charnwood Molecular.

Charnwood Molecular was founded in 1998 as a spin out from Loughborough University and is a leader in its field, helping pharmaceutical and biotech companies around the world with their drug development programmes.

The three-storey, research facility has been modernised by engineering firm Couch Perry Wilkes.

It follows the delivery of a number of complex projects for Charnwood Campus including 33,000 sq ft of laboratory space for the º£½ÇÊÓÆµ Department of Health and Social Care’s Lighthouse Lab, which briefly processed high volumes of samples for the º£½ÇÊÓÆµ’s test and trace programme.

The Charnwood Molecular block was paid for using £3.5 million of support from the Enterprise Zone reinvestment fund facilitated through co-operation with the Leicester and Leicestershire Enterprise Partnership (LLEP) and Charnwood Borough Council.

Charnwood Campus sits within a new enterprise zone which also takes in the Loughborough University Science and Enterprise Park and the Leicester Waterside area.

The new laboratories will provide substantial capacity for future growth and expansion of Charnwood Molecular’s medicinal chemistry and process research teams, as well as allow it to add drug discovery service lines.